Overview and Scope
Central nervous system (CNS) biomarkers refer to specific substances or measurable indicators in the CNS that provide information about normal functioning, disease processes, or responses to treatments within the CNS. These are used to diagnose or predict neurological disorders, monitor disease progression, and predict responses to drug therapy.
Sizing and Forecast
The central nervous system biomarkers market size has grown rapidly in recent years. It will grow from $5.01 billion in 2023 to $5.55 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rise in concerns regarding neurological disorders, high prevalence of central nervous system illnesses, growth in demand for enhanced diagnosis and treatment, improved healthcare infrastructure, rise in aging population.
The central nervous system biomarkers market size is expected to see strong growth in the next few years. It will grow to $8.02 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing prevalence of neurological disorders, growing demand for personalized medicine, rising geriatric population, increasing focus on early diagnosis, growing demand for non-invasive diagnostic tools. Major trends in the forecast period include new technological advancements, strategic collaborations between biotechnology companies, pharmaceutical companies, and other stakeholders, growth in research on cerebrospinal fluid (csf) and blood-based biomarkers, utilization of ai and machine learning algorithms.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report
Segmentation & Regional Insights
The central nervous system biomarkers market covered in this report is segmented –
1) By Type: Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other Types
2) By Disease: Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Traumatic Brain Injury, Other Diseases
3) By Application: Drug Discovery And Development, Personalized Medicines, Disease Risk Assessment, Diagnostics, Other Applications
4) By End-Users: Diagnostic Labs, Clinics, Hospitals, Research Centers, Other End-Users
North America was the largest region in the central nervous system biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the central nervous system biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12632&type=smp
Major Driver Impacting Market Growth
The rise in neurological illnesses is expected to propel the growth of the central nervous system biomarker market going forward. Neurological illnesses, also known as neurological disorders, refer to a broad range of conditions that affect the brain, spinal cord, and nerves throughout the body. These disorders can arise from various causes, including genetic factors, infections, autoimmune responses, degenerative processes, tumors, vascular issues, and traumatic injuries. In neurological disorders, central nervous system (CNS) biomarkers aid clinical diagnosis, determine illness risk or prognosis, assess disease stage, and track treatment response. They play a significant role in understanding these diseases and their ability to be treated. For instance, in April 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, Alzheimer’s disease affected an estimated 6.7 million Americans aged 65 and older. This number is expected to nearly triple to 14 million by 2060. Moreover, the number of people living with the disease doubles every five years after age 65. Therefore, the rise in neurological illnesses drives the growth of the central nervous system biomarker market.
Key Industry Players
Major companies operating in the central nervous system biomarkers market report are F. Hoffmann-La Roche AG, Novartis AG, Siemens Healthineers, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Eurofins Scientific, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Axon Neuroscience SE, Alector Inc., Oryzon Genomics S.A., Abastar Mdx Inc., Banyan Biomarkers Inc., Avacta Group PLC, Geno Technology Inc., Anavex Life Sciences Corp., Alseres Pharmaceuticals Inc., Aposense Ltd., Applied Neurosolutions Inc., C2N Diagnostics, Alzheon Inc., DiaGenic ASA, Abiant Inc., Avid Radiopharmaceuticals Inc., Acumen Pharmaceuticals Inc., Cassava Sciences Inc., Denali Therapeutics.
The central nervous system biomarkers market report table of contents includes:
1. Executive Summary
2. Central Nervous System Biomarkers Market Characteristics
3. Central Nervous System Biomarkers Market Trends And Strategies
4. Central Nervous System Biomarkers Market – Macro Economic Scenario
5. Global Central Nervous System Biomarkers Market Size and Growth
.
.
.
31. Central Nervous System Biomarkers Market Other Major And Innovative Companies
32. Global Central Nervous System Biomarkers Market Competitive Benchmarking
33. Global Central Nervous System Biomarkers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Central Nervous System Biomarkers Market
35. Central Nervous System Biomarkers Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
